The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

CAMBRIDGE, MA AND PITTSBURGH, PA / ACCESSWIRE / 10, 2025 / Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whol ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

Insert length between 800 and 3000 bp. ‡‡ One clone was resistant to all three antibiotic classes in a secondary screen. The generic term 'antibiotic' is used to denote any class of organic ...

If it gets a green light, it will be the first antibiotic in the beta-lactam class to or the treatment of SAB S. aureus, including hard-to-treat infections caused by methicillin-resistant strains ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or pharmacy.

In short: The Food and Drug Administration focuses on bugs instead of patients. You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics.